FDA Approvals for CME
The FDA approvals column highlights new drugs and devices for disease management, screening, and other therapeutic uses. Clinicians can learn about the drug indication, dosage and administration, clinical evidence leading to the approval, and other relevant information related to the newly approved drug or device for clinical practice.
FDA Approvals
- FDA Panel: Upper Airway Device Beneficial for OSA
- FDA Approval: Dapagliflozin for Type 2 Diabetes
- FDA Approval: Ferric Carboxymaltose for Iron-Deficiency Anemia
- FDA Approval: Pertuzumab for Neoadjuvant Treatment of Breast Cancer
- FDA Approval: Dolutegravir for HIV-1 Infection
- FDA Approval: Meningococcal Vaccine Now Approved for Infants and Toddlers
- FDA Approvals: Plasma-Derived Agent for Anticoagulation Reversal
- FDA Approvals: Dabrafenib and Trametinib for Metastatic Melanoma
- FDA Approvals: New Combo Inhaled Treatment of COPD
- FDA Approvals: Radium-223 for Advanced Prostate Cancer
Medscape is the funder and CME provider of the programs listed on this page. The findings and conclusions in these activities do not necessarily represent the formal position of the Food and Drug Administration.
Related Resources
Safe Use Center